229 related articles for article (PubMed ID: 15538315)
1. [Valpromide, Valproic acid and removal of small intestine in the treatment of a chronic depression: a case report].
Benjelloun G; Blandin K; Fossati P
Encephale; 2004; 30(4):400-3. PubMed ID: 15538315
[TBL] [Abstract][Full Text] [Related]
2. Disposition of valpromide, valproic acid, and valnoctamide in the brain, liver, plasma, and urine of rats.
Blotnik S; Bergman F; Bialer M
Drug Metab Dispos; 1996 May; 24(5):560-4. PubMed ID: 8723737
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and antiepileptic activity of valproyl hydroxamic acid derivatives.
Levi M; Yagen B; Bialer M
Pharm Res; 1997 Feb; 14(2):213-7. PubMed ID: 9090712
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic analysis and antiepileptic activity of tetra-methylcyclopropane analogues of valpromide.
Bialer M; Hadad S; Kadry B; Abdul-Hai A; Haj-Yehia A; Sterling J; Herzig Y; Yagen B
Pharm Res; 1996 Feb; 13(2):284-9. PubMed ID: 8932450
[TBL] [Abstract][Full Text] [Related]
5. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain.
Winkler I; Blotnik S; Shimshoni J; Yagen B; Devor M; Bialer M
Br J Pharmacol; 2005 Sep; 146(2):198-208. PubMed ID: 15997234
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective pharmacokinetic analysis and antiepileptic activity of N-2-hydroxypropyl valpromide, a central nervous system--active chiral valproylamide.
Wasserman M; Yagen B; Blotnik S; Papo N; Bialer M
Ther Drug Monit; 2001 Aug; 23(4):414-20. PubMed ID: 11477326
[TBL] [Abstract][Full Text] [Related]
8. An improved gas chromatographic determination of valproic acid and valpromide in plasma.
Pokrajac M; Miljković B; Spiridonović D; Varagić VM
Pharm Acta Helv; 1992; 67(8):237-40. PubMed ID: 1409759
[TBL] [Abstract][Full Text] [Related]
9. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic analysis and anticonvulsant activity of two polyesteric prodrugs of valproic acid.
Hadad S; Vree TB; van der Kleijn E; Bialer M
Biopharm Drug Dispos; 1993 Jan; 14(1):51-9. PubMed ID: 8427944
[TBL] [Abstract][Full Text] [Related]
11. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic considerations in the design of better and safer new antiepileptic drugs.
Bialer M
J Control Release; 1999 Nov; 62(1-2):187-92. PubMed ID: 10518650
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic analysis of ester prodrugs of valproic acid.
Hadad S; Vree TB; van der Kleijn E; Bialer M
J Pharm Sci; 1992 Oct; 81(10):1047-50. PubMed ID: 1432619
[TBL] [Abstract][Full Text] [Related]
14. Development of acute pancreatitis caused by sodium valproate in a patient with bipolar disorder on hemodialysis for chronic renal failure: a case report.
Okayasu H; Shinozaki T; Osone A; Ozeki Y; Shimoda K
BMC Psychiatry; 2014 Mar; 14():93. PubMed ID: 24679075
[TBL] [Abstract][Full Text] [Related]
15. The disposition of valpromide in rats and the isolated perfused rat liver.
Billig H; Ziv E; Bar-On H; Bialer M
Drug Metab Dispos; 1990; 18(2):238-44. PubMed ID: 1971580
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and anticonvulsant activity of three monoesteric prodrugs of valproic acid.
Badir K; Haj-Yehia A; Vree TB; van der Kleijn E; Bialer M
Pharm Res; 1991 Jun; 8(6):750-3. PubMed ID: 2062805
[TBL] [Abstract][Full Text] [Related]
17. Predictive ability of published population pharmacokinetic models of valproic acid in Thai manic patients.
Methaneethorn J; Leelakanok N
J Clin Pharm Ther; 2021 Feb; 46(1):198-207. PubMed ID: 32986889
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology of valpromide.
Bialer M
Clin Pharmacokinet; 1991 Feb; 20(2):114-22. PubMed ID: 2029804
[TBL] [Abstract][Full Text] [Related]
19. Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid.
Radatz M; Ehlers K; Yagen B; Bialer M; Nau H
Epilepsy Res; 1998 Mar; 30(1):41-8. PubMed ID: 9551843
[TBL] [Abstract][Full Text] [Related]
20. Valpromide increases amplitude of heart rate circadian rhythm in remitted bipolar and unipolar disorders. A placebo-controlled study.
Lemoine P; Fondarai J; Faivre T
Eur Psychiatry; 2000 Nov; 15(7):424-32. PubMed ID: 11112935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
